- Home
- Healthcare
- Airway Stent Lung Stent Market

Airway Stent Lung Stent Market Size, Share, Growth, and Industry Analysis, By Type (Tracheal Stents & Laryngeal Stents), By Application (Hospitals & Ambulatory Surgery Centres), and Regional Forecast to 2033
Region: Global | Format: PDF | Report ID: PMI3164 | SKU ID: 27159080 | Pages: 112 | Published : July, 2025 | Base Year: 2024 | Historical Data: 2020 - 2023
AIRWAY STENT LUNG STENT MARKET OVERVIEW
The global Airway Stent Lung Stent market size was USD 103.93 million in 2025 and is projected to touch USD 188.27 million by 2033, exhibiting a CAGR of 7.71% during the forecast period.
The airway stent lung stent market is a rapidly developing segment of the medical device industry that deals with breathing difficulties due to the obstruction of airways by tumors, strictures, or other airway disorders. Airway stents have been referred to as lung stents, which are tube-like devices that are passed into the trachea or bronchi to maintain air passages in an open state and provide proper air circulation to the lungs. These stents are of different sizes and shapes depending on clinical requirements, and they are constructed of materials such as silicone or metal. Rising cases of chronic respiratory diseases and the development of less invasive procedures are the trends that contribute to market growth. Product innovation and development is also being affected by the growing demand for stenting products that are customized and long-lasting.
GLOBAL CRISES IMPACTING AIRWAY STENT LUNG STENT MARKETCOVID-19 IMPACT
"Airway Stent Lung Stent Industry Had a Negative Effect Due to delayed procedures and supply disruptions"" ""during COVID-19 Pandemic"
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.
The COVID-19 pandemic created an adverse effect on the airway stent lung stent market, as most of the MIS elective services were disrupted, and hospitals redirected resources to emergency care. Non-emergency interventions such as airway stent placement in non-emergency conditions were delayed or cancelled, leading to a massive reduction in demand. The operations of the supply chain and delays in manufacturing more stents also contributed to the slowness of providing stents in the peak periods of the pandemic. Moreover, the decline in the number of visits to a physician and a decrease in the diagnosis of lung-related diseases also slowed down the market across the board. All these factors contributed to a conspicuous market loss and a sluggish product release within the industry.
LATEST TRENDS
"3D-printed Stents and Personalization Drive Market Growth"
A few noteworthy trends in the airway stent (lung stent) market are the development of biodegradable stents, increasing preference for minimally invasive procedures, and their application in pediatric and complex airway disorders. Among the most transformative trends is the introduction of 3D-printed patient-specific airway stents. According to individual anatomical data, these stents are produced to allow for better fit and less migration, resulting in better therapeutic results in tightly constrained cases. Technology developments in imaging and bronchoscopy are further enhancing this trend because they allow for targeted customization and placement. This rising alternating trend in personalization is changing how treatments undergo interventional pulmonology.
AIRWAY STENT LUNG STENT MARKET SEGMENTATION
BY TYPE
Based on Type, the global market can be categorized into Tracheal Stents & Laryngeal Stents
- Tracheal Stents: The tracheal stent is applied mainly to abrupt the trachea or narrowing of the trachea due to tumors or inflammation, among others. They are used to keep the airways open and facilitate breathing since they physically keep the trachea open. Due to the rising incidences of tracheal malignancies and the growing procedures of bronchoscopic interventions that are less invasive, the market of tracheal stents is stimulated. Innovations in stent materials, silicon and metal alloys, are improving patient outcomes and success rates of procedures.
- Laryngeal Stents: Laryngeal stents are created to stabilize the larynx and are frequently employed post-reconstructive surgeries or injuries to avoid collapse of the airway and help to heal. These stents come in handy in cases involving children and adults when the larynx needs temporary support in terms of structure. It is finding slow yet commendable growth in the market due to the progress made in the field of biocompatible material and better methods of post-surgical care. Nevertheless, issues such as migration of the stent and discomfort still hinder its wide application in clinical practice.
BY APPLICATION
Based on application, the global market can be categorized into Hospitals & Ambulatory Surgery Centres
- Hospitals: The inclusion of the use of an airway stent placement will be in the form of a hospital, since the hospitals have superior infrastructure and they have specialized departments of pulmonology and thoracic surgery. They treat most airway obstruction cases, which are complex and need intensive care or urgent care. Hospitals are a force to reckon with in the market due to the impressive patient traffic to their premises and the availability of highly qualified personnel. Moreover, the ability to conduct both emergency and elective surgeries guarantees the stable demand for airway and lung stents.
- Ambulatory Surgery Centers: ASCs are another developing part of the airway stent market, as they are also efficient at dealing with outpatient operations. This provides them with faster processing time and affordable procedures to treat patients that need non-complicated stent insertions. The tendency toward the use of less invasive procedures has made ASCs more suitable in airway stenting. Nevertheless, the share they have in the market is not as high as in the case with hospitals when it comes to emergency care, as they are not able to provide equal resources to take care of possible emergency cases.
MARKET DYNAMICS
Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.
DRIVING FACTOR
"Rising Respiratory Disorders and Aging Population Drive Market Growth Upward"
One of the main key drivers of the airway stent and lung stent market is the rising number of chronic respiratory disorders like chronic obstructive pulmonary disease (COPD), lung cancer, and tracheobronchial stenosis in most parts of the globe. Such conditions usually cause the airways to block, which necessitates stenting in order to have normal breathing. The number of patients requiring an airway intervention steadily increases with the rise in both aging of the population and air pollution, especially in the developing areas. This increase in demand is causing the healthcare systems to join more stenting procedures, which in turn is causing an increase in the market.
"Technological Innovation in Stents Is Boosting Market Growth"
Technological innovation in stent design and materials has been an immense contribution to the improvements in the efficacy and safety of airway stents. Contemporary stents are stiffer, more flexible, and have better placability and removal due to improved biocompatibility and satisfy patients. The 3D-printed and patient-specific stents are also on the rise, providing options to patch up complex airway anatomies in a personalized manner. Such developments are encouraging the role of broader clinical application and the rate of adoption by the healthcare industry.
RESTRAINING FACTOR
"Stent-related Complications and Safety Concerns Hinder Sustainable Market Growth"
The possibility of stent-related complications in terms of migration, infection, formation of granulation tissues, and perforation of the airway are also some of the restraining factors to the market. Such complications may prompt future medical procedures to treat the selected complication, which leads to a decline in patient confidence and the desire of a clinician to use the stenting procedure. Furthermore, the misapplication of stent insertions or sizes may lead to a poor result during more intricate airway forms. These safety issues restrict the wider usage and raise reliable difficulties in the sustainable market growth.
OPPORTUNITY
"Bioresorbable Stents Offer New Opportunities for Airway Market Growth"
One development that presents an upcoming opportunity for growth in the airway stent and lung stent market is the emerging prospect of developing and embracing bioresorbable stents. These stents will slowly lose their presence in the body slowly after serving the required purpose, hence not necessitating removal exercises. The innovation has a special intention towards pediatric and high-risk patients that cannot move without temporary airway assistance. Increased investment in research and clinical trials on bioresorbable materials is speeding up this trend. In case of successful commercialization of these stents, it will transform the airway management market and generate additional segments.
CHALLENGE
"Complex Anatomies and Guideline Gaps Restrict Market Growth"
One of the major threats to the Airway Stent Lung Stent Market Growth is the difficulty in the insertion of the stents in individuals who have irregular and extremely obstructed airway anatomies. Misdirection may result in defects including stent drift, tissue harm, or ineffective reestablishment of air circulation. Also, the absence of common guidelines in the selection and sizing of stents contributes to clinical challenges. This puts a restriction on mass use, particularly in areas where there is poor access to specialized medical knowledge and resources.
AIRWAY STENT LUNG STENT MARKET REGIONAL INSIGHTS
-
NORTH AMERICA
"Strong Healthcare and Innovation Drive North America Market Growth"
The North American market is leading the airway stent lung stent market because of its excellent healthcare system, established marketing of big players of medical devices, and high awareness of respiratory intervention. The area enjoys excellent reimbursement guidelines and is an early adopting region of new stent technologies. The United States has the highest share among the North American countries due to its high prevalence of lung diseases and its positive investment in clinical research. Another factor that pushes the United States Airway Stent Lung Stent Market is an aging population and a growing demand for low-invasive procedures. Ongoing improvement in technology and increasing acceptance by the FDA also enable the country to experience sustained development in the market.
-
EUROPE
"Aging Population and Innovation Drive Europe Market Growth"
Europe also has significant contributions in the Airway Stent Lung Stent Market Share because European countries are well developed to provide quality health facilities and have increasingly warmed up to using sophisticated respiratory care technologies. Excessive rates of chronic respiratory disease, particularly in the aging population, are escalating the need for airway stents in the region. Germany, the UK, and France are making investments in minimally invasive procedures and increasing access to bronchoscopic interventions. Also, favorable regulation and clinical partnerships in European countries are promoting innovation and commercial growth.
-
ASIA
"Rising Respiratory Issues and Access Boost Asia Market Growth"
Asia is emerging as one of the major countries adding to the airway stent and lung stent market because of their high population of patients and increasing respiratory complications. Increasing cases of air pollution, rapid urbanization, and rising smoking levels contribute significantly to the demand for airway stents in nations such as China and India. There is also evidence of improvement in healthcare navigational facilities in the region and increased use of non-invasive studies. Besides, airway stents are becoming more available in the Asian developing markets due to local manufacturing and affordable treatment methods.
KEY INDUSTRY PLAYERS
"Key Players' Innovation and Expansion Strategies Drive Market Growth"
The airway Stent Lung market is highly active by key players who are making sure that innovation, strategic alliances, and overseas locations are being done to consolidate the market. Boston Scientific, Cook Medical, and Micro-Tech are some of the companies that are spending intensively on research and development in the advancement of stent designs that will be more biocompatible and precise in nature. Partnerships with healthcare partners and research organizations are streamlining regulatory approval as well as clinical trials. Such players are still also increasing their business in emerging markets via mergers and acquisitions as well as local associations. Their propensity towards the presence of least invasive technologies as well as patient-specific solutions is improving the outcomes of procedures and increasing the rate of adoption, which is categorically improving the growth of the market itself.
LIST OF TOP AIRWAY STENT LUNG STENT COMPANIES
- Cook Group (U.S.)
- Novatech Sa (France)
- Fuji Systems (Japan)
- Endo-Flex (Germany)
- Taewoong Medical (South Korea)
KEY INDUSTRY DEVELOPMENT
October 2024: Peytant Solutions received U.S. FDA de novo clearance for its AMStent Tracheobronchial Covered Stent System, marking the first amnion-covered stent approved for treating airway obstructions caused by malignant neoplasms. The device pairs a metal frame with a human amniotic membrane, which helps reduce inflammation, mucus buildup, and stent migration—enhancing patient outcomes. This milestone reflects increasing regulatory recognition for innovative biologically based stent technologies in pulmonary care. With this clearance, Peytant is set to commercialize AMStent in the U.S. and potentially expand its platform to other airway and luminal conditions. This development underscores the evolving landscape of airway stent innovation, where grafted biological materials are enabling safer and more effective interventions.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.
Attributes | Details |
---|---|
Historical Year |
2020 - 2023 |
Base Year |
2024 |
Forecast Period |
2025 - 2033 |
Forecast Units |
Revenue in USD Million/Billion |
Report Coverage |
Reports Overview, Covid-19 Impact, Key Findings, Trend, Drivers, Challenges, Competitive Landscape, Industry Developments |
Segments Covered |
Types, Applications, Geographical Regions |
Top Companies |
Cook Group, Novatech Sa, Endo-Flex |
Top Performing Region |
North America |
Regional Scope |
|
Frequently Asked Questions
-
What value is the Airway Stent Lung Stent market expected to touch by 2033?
The global Airway Stent Lung Stent market is expected to reach USD 188.27 million by 2033.
-
What CAGR is the Airway Stent Lung Stent market expected to exhibit by 2033?
The Airway Stent Lung Stent market is expected to exhibit a CAGR of 7.71% by 2033.
-
What are the driving factors of the Airway Stent Lung Stent market?
Rising Prevalence of Chronic Respiratory Diseases & Advancements in Stent Technology to expand the market growth.
-
What are the key Airway Stent Lung Stent market segments?
The key market segmentation, which includes, based on type, the Airway Stent Lung Stent market is Tracheal Stents & Laryngeal Stents. Based on application, the Airway Stent Lung Stent market is classified as Hospitals & Ambulatory Surgery Centres.
Airway Stent Lung Stent Market
Request A FREE Sample PDF